Find anything about our product, search our documentation, and more. Enter a query in the search input above, and results will be displayed as you type.
Searching... 
Featured speakers
Jonathan Norris
Life Science
Managing Director, Healthcare at SVB
Mira Chaurushiya, Ph.D
Senior Partner, Westlake Village BioPartners
Deena Shakir
Partner, Lux Capital
Sarah Pringle
Health Tech Reporter, Axios
Strong venture fundraising for healthcare during times of uncertainty
The healthcare industry has seen exponential investment growth over the past several years, with Covid-19 creating enormous disruption and resulting opportunities for new technologies to emerge. In 2022, the healthcare industry continues to see strong investor fundraising activity despite a difficult public market and the slow decline in valuations. Company investment is down from 2021’s record activity but still at 2020’s pace.
The on-demand webinar features a panel of health care industry experts including Mira Chaurushiya, Ph.D, Senior Partner, Westlake Village BioPartners; Deena Shakir, Partner, Lux Capital; Jon Norris, Managing Director, Healthcare at SVB; and moderator Sarah Pringle, Health Tech Reporter, Axios.
Register to hear our panel of experts discuss:
• The investor outlook: Fundraising, investments and exits
• Potential impacts to the healthcare industry heading into a recession
• Women’s health and probable challenges due to the overturning of Roe v. Wade
• Biopharma, device, healthtech and dx/tools technology and trends to watch
Learn more about how SVB supports Global Life Science & Healthcare companies.
Additional resources
Blog | Life Science & Healthcare
Healthcare Trends 1H2022: Insights and advice for founders
The healthcare industry continues to see strong investor fundraising activity despite a difficult public market and a slow decline in valuations.
Case Study
Xilis
Xilis develops next-generation technologies for cancer patients and accelerates drug discovery and development. Read their case study to learn how SVB provided a venture debt facility which led to a healthy Series A valuation and $70 million.
Blog | Life Science & Healthcare
First quarter healthcare industry trends worth tracking
The article provides in-depth analysis of current healthcare industry trends for first quarter 2022 and the investment outlook for the rest of the year.
Case Study
Activ
Activ Surgical is pioneering intelligent scopes and robots that see what humans cannot. Read the case study to learn about their med device technology and how SVB tailored a debt solution that scaled with the company’s progress.
Blog | Life Science & Healthcare
Healthcare industry sectors: An overview of 2021
Get deep insights into the unprecedented activity in healthcare investments and exits by sector.
Case Study
Mythic
Mythic, a biopharma company is pioneering new antibody-drug conjugates to safely treat cancer patients. Read the case study to learn how creative and flexible debt solutions from SVB extended the company’s cash runway without diluting equity.
Case Study
Dice
Discover how a biopharmaceutical startup is changing the lives of people with psoriasis. Read the case study on how SVB banking services supported Dice Therapeutics' growth.
Case Study
Aledade
Aledade, a healthtech company that is helping physicians across the country deliver better care for their patients. Read how Aledade accelerated their growth and expansion with SVB's customized financing solutions.
Blog | Life Science & Healthcare
Preview